Skip to main content
. 2017 Feb 23;8:250. doi: 10.3389/fmicb.2017.00250

Table 1.

Rates of antibiotics resistance in eighty K. pneumoniae bloodstream isolates.

Antibiotics Number of isolates (%) P Number of isolates (%) P
Total (n = 80) ESBL (n = 22) Non-ESBL (n = 58) Total (n = 80) Carbapenemase (n = 12) Non-carbapenemase (N = 68)
Ceftazidime 25 (31.3) 11 (50.0) 14 (24.1) 0.0259 25 (31.3) 12 (100.0) 13 (19.1) <0.0001
Ceftriaxone 38 (47.5) 22 (100.0) 16 (27.6) <0.0001 38 (47.5) 12 (100.0) 26 (38.2) <0.0001
Cefepime 29 (36.3) 14 (63.6) 15 (25.9) 0.0017 29 (36.3) 12 (100.0) 17 (25.0) <0.0001
Cefotaxime 38 (47.5) 22 (100.0) 16 (27.6) <0.0001 38 (47.5) 12 (100.0) 26 (38.2) <0.0001
Cefuroxime 45 (56.3) 22 (100.0) 23 (39.7) <0.0001 45 (56.3) 12 (100.0) 33 (48.5) 0.0009
Amikacin 16 (20.0) 4 (18.2) 12 (20.7) 1.0000 16 (20.0) 10 (83.3) 6 (8.8) <0.0001
Gentamicin 33 (41.3) 17 (77.3) 16 (27.6) <0.0001 33 (41.3) 11 (91.7) 22 (32.4) 0.0004
Tobramycin 26 (32.5) 12 (54.5) 14 (24.1) 0.0095 26 (32.5) 11 (91.7) 15 (22.1) <0.0001
Piperacillin 42 (52.5) 22 (100.0) 20 (34.5) <0.0001 42 (52.5) 12 (100.0) 30 (44.1) 0.0004
Aztreonam 31 (38.8) 16 (72.7) 15 (25.9) 0.0001 31 (38.8) 12 (100.0) 19 (27.9) <0.0001
Ciprofloxacin 33 (41.3) 14 (63.6) 19 (32.8) 0.0122 33 (41.3) 12 (100.0) 21 (30.9) <0.0001
Levofloxacin 26 (32.5) 9 (40.9) 17 (29.3) 0.3227 26 (32.5) 12 (100.0) 14 (20.6) <0.0001
Ampicillin-sulbactam 42 (52.5) 19 (86.4) 23 (39.7) 0.0002 42 (52.5) 12 (100.0) 30 (44.1) 0.0004
Piperacillin-tazobactam 20 (25.0) 6 (27.3) 14 (24.1) 0.7725 20 (25.0) 12 (100.0) 8 (11.8) <0.0001
Imipenem 14 (17.5) 3 (13.6) 11 (19.0) 0.8176 14 (17.5) 12 (100.0) 2 (2.9) <0.0001
Meropenem 15 (18.8) 2 (9.1) 13 (22.4) 0.2972 15 (18.8) 12 (100.0) 3 (4.4) <0.0001
Trimethoprim-sulfamethoxazole 38 (47.5) 18 (81.8) 20 (34.5) 0.0002 38 (47.5) 7 (58.3) 31 (45.6) 0.4150